2XA-30244-24166
3 vaccinations
0 coded responses
9 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 785 / TX
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Pfizer-BioNTech
-
2021-02-18
Dose 2 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, DiarrheaAdult check-in
- 2021-03-18
- 2021-08-19
-
2022-01-03
Dose 3 — Moderna
- 2022-01-03
-
2022-01-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2022-01-08
- 2023-01-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2022-01-03 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.